Phase 2, BDTX-1535 and Black Diamond
Black Diamond reports encouraging Phase 2 data for BDTX-1535
Black Diamond Therapeutics (NASDAQ:BDTX) reported encouraging Phase 2 data for its drug candidate BDTX-1535 in the treatment of patients with recurrent EGFR-mutant non-small cell lung cancer, or NSCLC.
Buy Rating on Black Diamond Therapeutics: Promising Phase 2 Results for BDTX-1535 in NSCLC Treatment
Robert Burns, an analyst from H.C. Wainwright, reiterated the Buy rating on Black Diamond Therapeutics (BDTX – Research Report). The
Black Diamond Therapeutics Gains On Positive Phase 2 Data For BDTX-1535 In Patients With NSCLC
(RTTNews) - Black Diamond Therapeutics, Inc. (BDTX) announced positive initial Phase 2 results for BDTX-1535 in patients with relapsed or refractory non-small cell lung cancer also known as NSCLC, caused by epidermal growth factor receptor or EGFR mutations. Following this news, the stock is up 40% in the pre-market trade.
Black Diamond Therapeutics Shares Jump on Positive Data for Cancer Treatment
Shares in Black Diamond Therapeutics rose after the company outlined positive initial data from Phase 2 trials of BDTX-1535, an oral cancer treatment. Shares were up 46% in premarket trading at $6.94.
Black Diamond Therapeutics Inc (BDTX) Stock: Greater Than Its Current Valuation?
Raymond James has recently initiated Black Diamond Therapeutics Inc (BDTX) stock to Outper form rating, as announced on July 31, 2024, according to Finviz. Earlier, on July 14, 2023, Piper Sandler had initiated the stock to Overweight.
Black Diamond Therapeutics to Host Webcast Presentation of Initial Phase 2 BDTX-1535 Data in Patients With Recurrent EGFRm NSCLC
Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer, will host a webcast to disclose initial phase 2 clinical trial results for BDTX-1535 in patients with recurrent EGFRm NSCLC on Monday,
FierceBiotech4d
Black Diamond, Ideaya entertain registrational trial ideas as cancer drugs show midstage promise
Black Diamond Therapeutics and Ideaya Biosciences are mulling over registrational trials for their lead assets after ...
Black Diamond Therapeutics' Lead Drug Candidate Shows Initial Anti-tumor Activity In Certain Type Of Lung Cancer Resistant To AstraZeneca's Drug
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) reported initial Phase 2 data of BDTX-1535. The data demonstrated encouraging ...
GearJunkie on MSN21h
The Moves Should Be Hard, Not the Approach: Black Diamond Erratic Bouldering Crash Pad Review
Black Diamond's new Erratic bouldering crash pad is lighter and has a more substantial carrying system than others. The post ...
Business Insider9d
Buy Rating Affirmed for Black Diamond Therapeutics Amid Promising NSCLC Treatment Advances
Black Diamond Therapeutics (BDTX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Robert Burns from H.C. Wainwright reiterated a Buy rating ...
Returns Are Gaining Momentum At Black Diamond Group (TSE:BDI)
To find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'll want ...
Emma Coronel Walks the Runway in Milan for April Black Diamond
Emma Coronel, the wife of El Chapo, walked the runway yesterday, Sunday, September 22, in Milan in a wedding dress for April ...
Tribune Content Agency on MSN7h
Linda C. Black Horoscopes: September 27
Learn and discover valuable tricks this year. Dedicated physical practices strengthen your work, health and fitness for an ...
bleedingcool12d
Panick Entertainment Launch T.A.M.A, Savager & Black Diamond
Panick Entertainment has launched new titles on the crowdfunding platform Zoop with T.A.M.A, Savager and Black Diamond.
Voiceofmotown on MSN3d
WVU Projected to Go Bowling for the Black Diamond Trophy
Neal Brown, who is coming off of a 9-win campaign in 2023, will have to find four more wins if he hopes for his team to ...